Yu Nishida Selected Research

Antral

12/2020

Endoscopic findings of gastric lesions in patients with eosinophilic gastrointestinal disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Nishida Research Topics

Disease

10	Ulcerative Colitis 11/2023 - 01/2017
4	COVID-19 11/2023 - 12/2021
3	Crohn Disease (Crohn's Disease) 06/2023 - 01/2017
3	Infections 02/2022 - 01/2018
3	Ascites 01/2018 - 08/2011
2	Colitis 09/2021 - 01/2020
2	Neoplasms (Cancer) 12/2020 - 01/2013
2	Ulcer 12/2020 - 01/2020
2	Intestinal Obstruction (Obstruction, Intestinal) 02/2013 - 10/2012
1	Pneumonia (Pneumonitis) 11/2023
1	Chronic Disease (Chronic Diseases) 09/2023
1	Hepatolenticular Degeneration (Wilson's Disease) 06/2022
1	Spondylitis 02/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Eosinophilic Esophagitis 12/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2020
1	Pathologic Constriction (Stenosis) 06/2020
1	Inflammation (Inflammations) 01/2020
1	Pouchitis 01/2020
1	Rheumatoid Arthritis 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Pathologic Complete Response 01/2013
1	Tumor Lysis Syndrome 01/2013
1	Anuria 01/2013
1	Tuberculous Peritonitis 10/2012
1	Chemical and Drug Induced Liver Injury 10/2012
1	Hemorrhage 02/2012
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2012

Drug/Important Bio-Agent (IBA)

4	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 09/2017
3	Infliximab (Remicade)FDA Link 01/2018 - 01/2017
2	VaccinesIBA 10/2023 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2020
2	Immunologic Factors (Immunomodulators)IBA 06/2020 - 08/2019
1	Transaminases (Aminotransferases)IBA 11/2023
1	upadacitinibIBA 11/2023
1	Janus Kinase InhibitorsIBA 11/2023
1	Janus KinasesIBA 11/2023
1	SteroidsIBA 09/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2023
1	Ustekinumab (CNTO 1275)FDA Link 06/2023
1	CopperIBA 06/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	COVID-19 VaccinesIBA 12/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	AntralIBA 12/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Organic Anion TransportersIBA 01/2020
1	ProstaglandinsIBA 01/2020
1	SodiumIBA 01/2020
1	InflammasomesIBA 01/2020
1	Azathioprine (Imuran)FDA LinkGeneric 08/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	Toll-Like Receptor 9IBA 01/2016
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2012
1	Ethambutol (Myambutol)FDA LinkGeneric 10/2012
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2012
1	AcidsIBA 10/2012
1	Imatinib Mesylate (Gleevec)FDA Link 02/2012
1	Mesylates (Mesylate)IBA 02/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2011
1	Carboplatin (JM8)FDA LinkGeneric 08/2011

Therapy/Procedure

8	Therapeutics 09/2023 - 10/2012
2	Colectomy 09/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 02/2012 - 08/2011
1	Catheters 02/2022
1	Home Parenteral Nutrition 02/2022
1	Transplantation 09/2021
1	Restorative Proctocolectomy 01/2020
1	Conservative Treatment 01/2013
1	Aftercare (After-Treatment) 01/2013
1	Renal Dialysis (Hemodialysis) 01/2013
1	Endoscopic Hemostasis 02/2012